Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.82 - $1.32 $8 - $13
-10 Reduced 83.33%
2 $0
Q4 2022

Feb 10, 2023

SELL
$0.64 - $1.31 $51 - $106
-81 Reduced 87.1%
12 $0
Q3 2022

Nov 14, 2022

SELL
$0.8 - $1.65 $327 - $674
-409 Reduced 81.47%
93 $0
Q2 2022

Aug 12, 2022

SELL
$0.56 - $3.25 $165,555 - $960,810
-295,634 Reduced 99.83%
502 $0
Q1 2022

May 16, 2022

BUY
$2.46 - $5.92 $22,157 - $53,321
9,007 Added 3.14%
296,136 $894,000
Q4 2021

Feb 08, 2022

BUY
$4.26 - $23.33 $1.19 Million - $6.49 Million
278,359 Added 3173.99%
287,129 $1.48 Million
Q3 2021

Nov 15, 2021

BUY
$18.12 - $28.5 $158,912 - $249,945
8,770 New
8,770 $212,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $53.9M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.